Meeting Coverage:

EURETINA Congress

EURETINA: 2018

Is There Any Hope for Dry AMD Patients?

Show Description +

Anat Loewenstein, MD, and William Tucker, MD, review the treatment options for patients with dry age-related macular degeneration (AMD), including the potential effectiveness of the use of stem cells, complement inhibitions, and electronic implantation.

Posted: 9/21/2018

Up Next


Three Exciting New Drugs

Pravin U. Dugel, MD

Value of Recent Surgical Innovations

José García-Arumí, MD, PhD

The One Thing Every Doctor Can Do to Improve Efficiency in the Office

Nadia K. Waheed, MD, MPH, Pravin U. Dugel, MD

Disrupted Imaging on OCTA

Nadia K. Waheed, MD, MPH

Micropulse Laser in BRVO

Matteo Forlini, MD

Gene Therapy in Retinitis Pigmentosa

Robert E. MacLaren, MB, ChB, DPhil, FRCOphth, FRCS, FACS, FMedSci

Can We Get Smaller Than 27-Gauge Instrumentation?

José García-Arumí, MD, PhD, Robert E. MacLaren, MB, ChB, DPhil, FRCOphth, FRCS, FACS, FMedSci

Management of RVO

Anat Loewenstein, MD

Is There Any Hope for Dry AMD Patients?

Anat Loewenstein, MD, William Tucker, MD

Is There Any Hope for Dry AMD Patients?

Anat Loewenstein, MD, and William Tucker, MD, review the treatment options for patients with dry age-related macular degeneration (AMD), including the potential effectiveness of the use of stem cells, complement inhibitions, and electronic implantation.

Posted: 9/21/2018


Please log in to leave a comment.

More From EURETINA: 2018 Coverage

Three Exciting New Drugs

Pravin U. Dugel, MD

Value of Recent Surgical Innovations

José García-Arumí, MD, PhD

The One Thing Every Doctor Can Do to Improve Efficiency in the Office

Nadia K. Waheed, MD, MPH, Pravin U. Dugel, MD